Alpha 2.0
Login Register
» Articles » PMID: 16091758

Coffee and Risk of Death from Hepatocellular Carcinoma in a Large Cohort Study in Japan

Overview
Journal Br J Cancer
Specialty Oncology
Date 2005 Aug 11
PMID 16091758
Citations 24
Authors
Y Kurozawa
I Ogimoto
A Shibata
T Nose
T Yoshimura
H Suzuki
R Sakata
Y Fujita
S Ichikawa
N Iwai
A Tamakoshi
Affiliations
Soon will be listed here.
Abstract

We examined the relation between coffee drinking and hepatocellular carcinoma (HCC) mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). In total, 110,688 cohort members (46,399 male and 64,289 female subjects) aged 40-79 years were grouped by coffee intake into three categories: one or more cups per day, less than one cup per day and non-coffee drinkers. Cox proportional hazards model by SAS was used to obtain hazard ratio of HCC mortality for each coffee consumption categories. The hazard ratios were adjusted for age, gender, educational status, history of diabetes and liver diseases, smoking habits and alcohol. The hazard ratio of death due to HCC for drinkers of one and more cups of coffee per day, compared with non-coffee drinkers, was 0.50 (95% confidence interval 0.31-0.79), and the ratio for drinkers of less than one cup per day was 0.83 (95% confidence interval 0.54-1.25). Our data confirmed an inverse association between coffee consumption and HCC mortality.

Citing Articles

All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study.

Kennedy O, Fallowfield J, Poole R, Hayes P, Parkes J, Roderick P BMC Public Health. 2021; 21(1):970.

PMID: 34154561 PMC: 8218514. DOI: 10.1186/s12889-021-10991-7.

Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Inoue M, Tsugane S Curr Nutr Rep. 2019; 8(3):182-186.

PMID: 30977056 DOI: 10.1007/s13668-019-0274-1.

Coffee consumption and liver cancer risk in Japan: a meta-analysis of six prospective cohort studies.

Tamura T, Hishida A, Wakai K Nagoya J Med Sci. 2019; 81(1):143-150.

PMID: 30962663 PMC: 6433635. DOI: 10.18999/nagjms.81.1.143.

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.

Chang C, Chuang C, Tsai M, Hsin I, Hsu S, Huang H Int J Mol Sci. 2019; 20(7).

PMID: 30925782 PMC: 6480428. DOI: 10.3390/ijms20071566.

Association between coffee consumption and all-sites cancer incidence and mortality.

Sado J, Kitamura T, Kitamura Y, Sobue T, Nishino Y, Tanaka H Cancer Sci. 2017; 108(10):2079-2087.

PMID: 28746796 PMC: 5623740. DOI: 10.1111/cas.13328.

References
1.
La Vecchia C, Negri E, Cavalieri dOro L, Franceschi S . Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev. 1998; 7(4):315-20. DOI: 10.1097/00008469-199808000-00007. View
2.
Corrao G, Lepore A, Torchio P, Valenti M, Galatola G, DAmicis A . The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol. 1994; 10(6):657-64. DOI: 10.1007/BF01719277. View
3.
Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C . Does coffee protect against hepatocellular carcinoma?. Br J Cancer. 2002; 87(9):956-9. PMC: 2364316. DOI: 10.1038/sj.bjc.6600582. View
4.
La Vecchia C, Negri E, Decarli A, DAvanzo B, Franceschi S . Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer. 1988; 42(6):872-6. DOI: 10.1002/ijc.2910420614. View
5.
Yoshizawa H . Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology. 2002; 62 Suppl 1:8-17. DOI: 10.1159/000048270. View